跳至主要内容
临床试验/NCT05998265
NCT05998265尚未招募不适用

A Randomised, Controlled, Open-Label, Multi-Centre Study to Evaluate the Efficacy of FeetMe® Home-Bases Rehabilitation Program in Comparison to Conventional Physiotherapy in Patients With Parkinson's Disease Using Connected Insoles

FeetMe0 个研究点目标入组 150 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
FeetMe
入组人数
150
主要终点
Gait velocity

研究概览

简要总结

The goal of this clinical trial is to compare home based rehalitation program with real time biofeeback versus conventional physiotherapy on the gait velocity in Parkinson disease. The main question[s] it aims to answer are:

• How do the interventions afftect the gait velocity of the participants at week 12 ? Participants will be randomized to either follow prescribtional physiotherapy or FeetMe rehabilitation programs during the first 12 weeks.

At the end of 12 weeks, participants will choose in which arm they want to pursue for 12 aditionnal weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent to participate in the study.
  • Male or female patients between 40 to 70 years of age, inclusive.
  • Body weight range of 40 kg to120 kg and a body mass index (BMI) of 18 to 34 kg/m
  • Diagnosis of Idiopathic Parkinson's disease (PD) according to UK Brain Bank Criteria (2/3 symptoms), with Hoehn and Yahr (H&Y) staging level 2, 2.5 or
  • Disease onset of at least 3 years prior to enrolment.
  • Patients with a history of 50% of levodopa responsiveness based on motor signs.
  • On stable treatment of PD medication for at least 30 days before screening and with no expected major changes during the first 3 months of the study.
  • Prescription for physiotherapy available.
  • Ability to walk without aid for at least 6 minutes.
  • Shoe size between 35 - 46 (European Standard).
  • Intact skin on feet.
  • Adequate visual and auditory acuity to perform the rehabilitation program and the assessments in the Investigator's judgement.
  • Comfortable with the use of a smartphone. If assistance is required for the use of FeetMe technology, a caregiver or volunteer is fully available to assist the patient.
  • Willingness to be regularly contacted via phone-calls.
  • Willingness to suspend conventional physiotherapy treatment and start the FeetMe rehabilitation program, if applicable.
  • French speaker.

排除标准

  • Medical history indicating a Parkinsonian syndrome other than idiopathic PD.
  • Unable to walk without walking aid or presence of an injury preventing the patient to walk.
  • Any relevant comorbidity or vestibular/visual dysfunctions limiting locomotion or balance.
  • Clinically significant comorbidities which in the judgement of the investigator may preclude the reliable gait assessment of the patient.
  • Patients with poor wound healing or broken skin on the feet.
  • Patients with foot implants.
  • Montreal Cognitive Assessment (MoCA) score ≤ 24/
  • Patients with dementia.
  • Patients with apathy.
  • Participation in another clinical trial with an investigational drug/ therapeutic within the three months before screening and during the study, unless agreed by the Sponsor.
  • Patients who had Lee Silverman Voice Treatment (LSVT) Big therapy within the past 12 months or have it planned during the course of the study.
  • Patients with Deep Brain Stimulation planned during the first 12 weeks of the study.
  • Patients with pacemakers.
  • Patients performing vigorous exercise > three times a week, 30 mins or more per session.

结局指标

主要结局

Gait velocity

时间窗: Week 12

Change from baseline to Week 12 (Visit 3) in gait velocity (cm/s) assessed during the 6 Minutes Walk-Test (6MWT).

次要结局

  • Stance time variability(Week 12)

研究者

发起方
FeetMe
申办方类型
Industry
责任方
Sponsor

相似试验